M. Božić

Savremena terapija hroničnog hepatitisa C: efikasnost i mogućnost predviđanja terapijskog odgovora

I. Milošević, K. Bojović, M. Božić, 2011 .

Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis.

J. Nikolić, O. Nedić, M. Bulajic, 2000, Clinica chimica acta; international journal of clinical chemistry.

SEQUENCE VARIABILITY AT THE INTERNAL RIBOSOME ENTRY SITE OF THE HCV GENOME IN RELATION TO THERAPY OUTCOME

G. Stamenkovic, Jasmina Simonović-Babić, M. Božić, 2009 .

The relation between anti-albumin antibodies and HBeAg/anti-HBe status as a marker of HB virus replication.

M. Božić, L. Tosić, N. Milošević-Jovčić, 1988, Hepato-Gastroenterology.

Concurrent quantitation of the A and D genotypes of hepatitis B virus.

S. Schaefer, H. Niesters, N. Tanić, 2009, Journal of virological methods.

Treatment of chronic hepatitis C with pegylated-interferon

D. Delić, M. Božić, R. Ješić, 2003 .

[Inadequate burials as an important factor in plague epidemic amongst Serbs in the Habsburg monarchy by the end of the 18th century: a historical analysis].

M. Božić, Snežana Božanić, G. Vasin, 2014, Srpski arhiv za celokupno lekarstvo.